Maximus (NYSE:MMS) Issues FY 2026 Earnings Guidance

Maximus (NYSE:MMS) issued an update on its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 7.900-8.200 for the period, compared to the consensus estimate of 8.430. The company issued revenue guidance of $5.2 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion.

Analyst Ratings Changes

A number of brokerages recently commented on MMS. Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, Maximus has a consensus rating of “Hold”.

Maximus Trading Down 7.6%

NYSE:MMS traded down $4.82 on Thursday, reaching $58.34. The company’s stock had a trading volume of 1,188,121 shares, compared to its average volume of 589,623. Maximus has a 1-year low of $52.73 and a 1-year high of $100.00. The business’s 50-day moving average price is $58.68 and its two-hundred day moving average price is $67.52. The firm has a market cap of $3.06 billion, a PE ratio of 8.73 and a beta of 0.59. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the firm posted $2.16 earnings per share. Maximus’s revenue was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Equities research analysts anticipate that Maximus will post 8.43 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Friday, August 14th. Maximus’s dividend payout ratio is presently 19.76%.

Institutional Investors Weigh In On Maximus

Several large investors have recently made changes to their positions in MMS. Advisory Services Network LLC acquired a new stake in Maximus in the 3rd quarter valued at approximately $32,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Maximus by 225.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock valued at $38,000 after buying an additional 304 shares in the last quarter. Canada Pension Plan Investment Board acquired a new position in shares of Maximus during the 2nd quarter worth about $35,000. Danske Bank A S acquired a new position in Maximus during the third quarter worth approximately $55,000. Finally, Kestra Advisory Services LLC acquired a new stake in Maximus during the 4th quarter valued at $89,000. Institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.